DIVE INTO DIALYSIS: Fresenius Expanding To Provide Complete Care For End-Stage Renal Disease Patients
This article was originally published in Clinica
In the final instalment of Clinica’s three-part series looking at companies occupying different points of the dialysis market spectrum, Reed Miller talked to the senior management of Fresenius Medical Care, to find out the firm’s strategy for maintaining its leading position in the face of growing competition
You may also be interested in...
The FAST 01 feasibility trial is evaluating a modification to Varian’s ProBeam particle accelerator that enables ultra-high dose radiation to treat cancer.
Data from the EARLY AF First, Cryo-FIRST and STOP AF trials show cryoablation is a better option than drugs for patients with symptomatic atrial fibrillation.
In this week’s podcast, Marion Webb reviews her interview with Glooko CEO Russ Johannesson and Reed Miller explains how Boston Scientific is restructuring its transcatheter aortic valve business.